182 related articles for article (PubMed ID: 30569167)
1. MiR‑495 suppresses cell proliferation by directly targeting HMGA2 in lung cancer.
Sun J; Qiao Y; Song T; Wang H
Mol Med Rep; 2019 Mar; 19(3):1463-1470. PubMed ID: 30569167
[TBL] [Abstract][Full Text] [Related]
2. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.
Sun X; Xu M; Liu H; Ming K
Mol Med Rep; 2017 Sep; 16(3):3557-3564. PubMed ID: 28714014
[TBL] [Abstract][Full Text] [Related]
4. microRNA-363-3p inhibits cell growth and invasion of non‑small cell lung cancer by targeting HMGA2.
Jiang C; Cao Y; Lei T; Wang Y; Fu J; Wang Z; Lv Z
Mol Med Rep; 2018 Feb; 17(2):2712-2718. PubMed ID: 29207105
[TBL] [Abstract][Full Text] [Related]
5. HMGA2 regulates lung cancer proliferation and metastasis.
Gao X; Dai M; Li Q; Wang Z; Lu Y; Song Z
Thorac Cancer; 2017 Sep; 8(5):501-510. PubMed ID: 28752530
[TBL] [Abstract][Full Text] [Related]
6. Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors.
Gao N; Wang FX; Wang G; Zhao QS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1693-1699. PubMed ID: 29630114
[TBL] [Abstract][Full Text] [Related]
7. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
8. MicroRNA‑363‑3p inhibits hepatocarcinogenesis by targeting HMGA2 and is associated with liver cancer stage.
Wang J; Liang H; Ge H; Guo X; Gu D; Yuan Y
Mol Med Rep; 2019 Feb; 19(2):935-942. PubMed ID: 30535489
[TBL] [Abstract][Full Text] [Related]
9. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
10. miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2.
Liao H; Liang Y; Kang L; Xiao Y; Yu T; Wan R
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760169
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
Xiong L; Tang Y; Tang J; Liu Z; Wang X
Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
[No Abstract] [Full Text] [Related]
12. Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis.
Wu X; Li X; Xu G
Oncol Rep; 2020 Aug; 44(2):487-498. PubMed ID: 32468043
[TBL] [Abstract][Full Text] [Related]
13. miR‑497 suppresses malignant phenotype in non‑small cell lung cancer via targeting KDR.
Xia Y; Hu C; Lian L; Hui K; Wang L; Qiao Y; Liu L; Liang L; Jiang X
Oncol Rep; 2019 Jul; 42(1):443-452. PubMed ID: 31115562
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑28 promotes the proliferation of non‑small‑cell lung cancer cells by targeting PTEN.
Cui F; Zhou Q; Xiao K; Qian H
Mol Med Rep; 2020 Jun; 21(6):2589-2596. PubMed ID: 32236614
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑495 targets Notch1 to prohibit cell proliferation and invasion in oral squamous cell carcinoma.
Lv L; Wang Q; Yang Y; Ji H
Mol Med Rep; 2019 Jan; 19(1):693-702. PubMed ID: 30387817
[TBL] [Abstract][Full Text] [Related]
16. circUBAP2 regulates osteosarcoma progression via the miR‑204‑3p/HMGA2 axis.
Ma W; Xue N; Zhang J; Wang D; Yao X; Lin L; Xu Q
Int J Oncol; 2021 Mar; 58(3):298-311. PubMed ID: 33650644
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.
Li K; Yuan C
Int J Mol Med; 2020 Sep; 46(3):1013-1028. PubMed ID: 32582959
[TBL] [Abstract][Full Text] [Related]
18. miR‑491‑3p functions as a tumor suppressor in non‑small cell lung cancer by targeting fibroblast growth factor 5.
Zhang G; Zheng H; Wang L
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866594
[TBL] [Abstract][Full Text] [Related]
19. miR‑379‑5p inhibits cell proliferation and promotes cell apoptosis in non‑small cell lung cancer by targeting β‑arrestin‑1.
Jiang Y; Zhu P; Gao Y; Wang A
Mol Med Rep; 2020 Dec; 22(6):4499-4508. PubMed ID: 33173959
[TBL] [Abstract][Full Text] [Related]
20. miR‑671‑3p is downregulated in non‑small cell lung cancer and inhibits cancer progression by directly targeting CCND2.
Yao Y; Zhou Y; Fu X
Mol Med Rep; 2019 Mar; 19(3):2407-2412. PubMed ID: 30664171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
